Switch to Bing in English
Copilot
あなたの日常的な AI アシスタント
約 59,400 件の結果
  1. Clearance of senescent cells by ABT263 rejuvenates aged ...

  2. 他の人はこちらも質問
    ABT‐263 exerts its senolytic activity in senescent tumor cells by inhibiting BCL‐X L 's interaction with BAX Members of the BCL‐2 family regulate the survival of different types of malignant cells and have also been shown to mediate the resistance of senescent cells to cell death [ 38, 39 ].
    To test this idea, we screened a collection of compounds and identified ABT263 (a specific inhibitor of the anti-apoptotic proteins BCL-2 and BCL-xL) as a potent senolytic drug. We show that ABT263 selectively kills SCs in culture in a cell type- and species-independent manner by inducing apoptosis.
    Clearance of therapy-induced senescent tumor cells by the senolytic ABT-263 via interference with BCL-XL -BAX interaction Tumor cells undergo senescence in response to both conventional and targeted cancer therapies.
    Here, the effects of the senolytic agent ABT-263 on the survival of irradiated A549 and Ca9-22 cancer cells were investigated. ABT-263 was added to the culture medium after irradiation. SA-β-gal activity and cell size, which are hallmarks of cell senescence, were evaluated using a flow cytometer.
  3. Using proteolysis-targeting chimera technology to reduce ...

  4. Discovering small-molecule senolytics with deep neural networks

  5. Clearance of therapy-induced senescent tumor cells by the ...

  6. 幹細胞:ABT263による老化細胞の除去はマウスの老化した造血幹 ...

  7. Treatment with the BCL-2/BCL-xL inhibitor senolytic drug ...

  8. Clearance of senescent cells with ABT-263 improves ...

このサイトを利用すると、分析、カスタマイズされたコンテンツ、広告に Cookie を使用することに同意したことになります。サード パーティの Cookie に関する詳細情報|Microsoft のプライバシー ポリシー